A/s Novo, 10% Owner at Tobira Therapeutics, Inc. (TBRA), sold 225,000 shares at $9.76 ($2.2M) on 2015-11-18, disclosed to the SEC on 2015-11-19.
Open-market sale of $2.2M TBRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.87 | 71,399 | $705K | 32.0% |
| 2 | $9.76 | 153,601 | $1.5M | 68.0% |
| Total | $9.79 avg | 225,000 | $2.2M | 100% |
| Filing → |
| RETA | SELL | 2017-06-12 | $5.7M | — | Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |